John F. Sullivan - 30 Aug 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP of Quality & Engineering
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
30 Aug 2021
Net transactions value
+$896
Form type
4
Filing time
01 Sep 2021, 17:04:44 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $896 +3,200 +29% $0.2800* 14,273 30 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3,200 -17% $0.000000 15,772 30 Aug 2021 Common Stock 3,200 $0.2800 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 245 shares acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan.
F2 The option is fully vested.